News|Articles|November 2, 2004
- Pharmaceutical Technology-11-02-2004
- Volume 28
- Issue 11
Method Validation by Phase of Development: An Acceptable Analytical Practice
This article provides guidance for minimally acceptable method validation practices and a foundation for assessing the risks and benefits associated with method validation programs.
Advertisement
Articles in this issue
almost 21 years ago
Still Waiting for Answersalmost 21 years ago
Comparing and Contrasting Barrier Isolator Decontamination Systemsalmost 21 years ago
November 2004almost 21 years ago
In the Spotlight-November 2004almost 21 years ago
Searching for a Viable Business Modelalmost 21 years ago
FDA Moves To Implement New GMP PoliciesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
2
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
3
PharmTech Weekly News Roundup — Week of October 27, 2025
4
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
5
